Direct oral anticoagulants: a review on the current role and scope of reversal agents

R Chaudhary, T Sharma, J Garg, A Sukhi… - Journal of thrombosis …, 2020 - Springer
New guideline recommendations prefer direct oral anticoagulants (DOACs) over warfarin in
DOAC-eligible patients with atrial fibrillation and patients with venous thromboembolism. As …
被引用次数：62 相关文章

Direct oral anticoagulants: a review on the current role and scope of reversal agents

C Rahul, T Sharma, G Jalaj, S Ajaypaul… - … of Thrombosis and …, 2020 - search.proquest.com
New guideline recommendations prefer direct oral anticoagulants (DOACs) over warfarin in
DOAC-eligible patients with atrial fibrillation and patients with venous thromboembolism. As …

Direct oral anticoagulants: a review on the current role and scope of reversal agents.

R Chaudhary, T Sharma, J Garg, A Sukhi… - … of Thrombosis and …, 2020 - europepmc.org
New guideline recommendations prefer direct oral anticoagulants (DOACs) over warfarin in
DOAC-eligible patients with atrial fibrillation and patients with venous thromboembolism. As …

[引用][C] Direct oral anticoagulants: a review on the current role and scope of reversal agents

R Chaudhary, T Sharma, J Garg… - Journal of …, 2020 - lomalinda.elsevierpure.com
Direct oral anticoagulants: a review on the current role and scope of reversal agents — Faculty
Research (Pure) - Loma Linda University Skip to main navigation Skip to search Skip to main …

Direct oral anticoagulants: a review on the current role and scope of reversal agents

R Chaudhary, T Sharma, J Garg… - … of thrombosis and …, 2020 - pubmed.ncbi.nlm.nih.gov
New guideline recommendations prefer direct oral anticoagulants (DOACs) over warfarin in
DOAC-eligible patients with atrial fibrillation and patients with venous thromboembolism. As …